Global Renal Disease market is Expected to Grow at a CAGR of 6.3% from 2017 to 2023

“Renal disease Market”
Market research future has a half cooked research report on Global Renal disease Market. The global market for Renal Disease market is growing continuously and expected to grow at a CAGR of 6.3% from 2017 to 2023

Global Renal disease Market information, by type (Acute kidney problems, Chronic kidney diseases, and others), by Diagnosis (Blood tests, Urine tests, Imaging tests, Removing a sample of kidney tissue for testing, and others), by Treatment (Medications, Dialysis, Kidney transplant, Surgery, Diet and others) – Forecast to 2023

The global renal disease market has been evaluated as moderately growing market and it is expected that the market will continue to grow similarly in the near future. Increasing prevalence of kidney related diseases is major driving force of the market. According to National Kidney Foundation, Inc., 10% population is suffering from chronic kidney diseases throughout the globe. According to Global Burden of Disease study, kidney disease is one of the major cause for the death throughout the world and racked 18th in 2010. Technological advancement and new product development are providing tremendous opportunities in this market. The market for renal disease was around US$ 9,318.3 million in 2016 and is expected to reach US$ 14,291.2 million which is projected to grow at a CAGR of 6.3% by 2023.

 Sample Report Available at .

Major Players in Renal disease Market:

There are plenty of large and small market players which operate in this market: Abbott (US), Amgen Inc. (US), Baxter (US), Bristol-Myers Squibb Company (US), Keryx Biopharmaceuticals, Inc. (US), NephroGenex, Inc. (US), Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi (France), Shire Pharmaceuticals Limited (Republic of Ireland), and others.

The renal disease market is one of the growing market and attracting many players towards it. Major brands are holding largest share in this market while medium and small companies are also performing well. The main focus of most of the companies is R&D and new product development. Increasing funding in R&D is showing positive impact on market and leading the market growth. These companies are also working with hospitals to provide better solutions to the patients. Changing healthcare practices and rapid adoption of new techniques are creating many opportunities in this market. The market for renal diseases in emerging economies is rising and major players are focusing on these regions.

Regional Analysis:

Considering the global scenario of the renal disease market, North America was holding largest market share in global renal disease market in 2016. While the European market is second largest, especially Western Europe is growing with faster rate and contributes largest share in European market. Due to rising healthcare expenditure and increasing awareness for the new products and therapies, Asia-Pacific region will be fastest growing market for renal disease during the forecast period. Middle East and Africa is expected to grow at steady pace during the forecast period.


Global Renal disease Market has been segmented on the basis of type which comprise acute kidney problems (Prerenal, Postrenal, Renal and others), chronic kidney diseases, and others. On the basis of diagnosis, it segmented into Blood Tests (Serum Creatinine, Glomerular Filtration Rate(GFR), Blood Urea Nitrogen (BUN), fasting blood glucose test), Urine test (Urinalysis, Protein urine test, Microalbuminuria test, Creatinine Clearance test), Imaging test (Ultrasound, CT Scan ), Removing a sample of kidney tissue for testing and others. On the basis of treatment, it segmented into medication (High blood pressure medications, Medications to lower cholesterol levels, Medications to treat anemia, Medications to relieve swelling, Medications to protect your bones), Dialysis (Hemodialysis, Peritoneal dialysis), kidney transplant (Deceased-donor kidney transplant, Living-donor kidney transplant, Pre-emptive kidney transplant ), surgery (Nephrectomy and radical nephrectomy, nephron-sparing surgery (NSS), nephrolithotripsy , Extracorporeal shock wave lithotripsy (ESWL), and others), diet and others.

Browse complete report at .

Table of Content

1.    Report Prologue

2.    Introduction

2.1    Definition

2.2    Scope of the Study

2.2.1    Research Objective

2.2.2    Assumptions

2.2.3    Limitations

2.3    Market Structure

2.4.    Market Segmentation

3.    Research Methodology

3.1    Research Process

3.2    Primary Research

3.3    Secondary Research

3.4    Market Size Estimation

3.5    Forecast Model


Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India